{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:57:02Z","timestamp":1789261022423,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":2119,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K24DK101828"],"award-info":[{"award-number":["K24DK101828"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F30DK095545"],"award-info":[{"award-number":["F30DK095545"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24DA034621"],"award-info":[{"award-number":["K24DA034621"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K23CA177321"],"award-info":[{"award-number":["K23CA177321"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/ajt.13976","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T04:03:00Z","timestamp":1469505780000},"page":"519-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Changes in Utilization and Discard of Hepatitis C\u2013Infected Donor Livers in the Recent Era"],"prefix":"10.1016","volume":"17","author":[{"given":"M.G.","family":"Bowring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Kucirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Massie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rakestraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gurakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13976_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cld.2005.08.004","article-title":"Treatment of hepatitis C after liver transplantation","volume":"9","author":"Berenguer","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1111\/ajt.13976_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2005.01.011","article-title":"What determines the natural history of recurrent hepatitis C after liver transplantation?","volume":"42","author":"Berenguer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13976_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1600-6143.2007.02126.x","article-title":"Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation","volume":"8","author":"Berenguer","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13976_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13976_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/lt.23669","article-title":"Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation","volume":"19","author":"Pungpapong","year":"2013","journal-title":"Liver Transpl"},{"issue":"1 Suppl.","key":"10.1111\/ajt.13976_bib6","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jhep.2014.07.020","article-title":"Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation","volume":"61","author":"Gambato","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13976_bib7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13976_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience","volume":"60","author":"Coilly","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13976_bib9","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13976_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.13976_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/lt.24366","article-title":"Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the Hepatitis C Therapeutic Registry and Research Network","volume":"22","author":"Brown","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13976_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.27681","article-title":"Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation","volume":"61","author":"Forns","year":"2015","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13976_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.dld.2014.06.004","article-title":"Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late","volume":"46","author":"Pellicelli","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1111\/ajt.13976_bib14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with sofosbuvir and ribavirin for HCV infection with advanced cirrhosis or post-liver transplant recurrence","volume":"63","author":"Poordad","year":"2016","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13976_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(16)00052-9","article-title":"Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: A multicentre, open-label, randomised, phase 2 trial","volume":"16","author":"Manns","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/ajt.13976_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/lt.24505","article-title":"Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3\/F4) after liver transplantation: Results from the CO23 ANRS CUPILT study","author":"Dumortier","year":"2016","journal-title":"Liver Transpl"},{"issue":"Suppl. 2","key":"10.1111\/ajt.13976_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13197","article-title":"OPTN\/SRTR 2013 Annual Data Report: Liver","volume":"15","author":"Kim","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13976_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/ajt.13089","article-title":"Heterogeneity and disparities in the use of exception scores in pediatric liver allocation","volume":"15","author":"Hsu","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13976_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/lt.23551","article-title":"Projected future increase in aging hepatitis C virus-infected liver transplant candidates: A potential effect of hepatocellular carcinoma","volume":"18","author":"Biggins","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13976_bib20","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2015080934","article-title":"Early changes in kidney distribution under the new allocation system","volume":"27","author":"Massie","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13976_bib21","first-page":"1","article-title":"Effective communication of standard errors and confidence intervals","volume":"1","author":"Louis","year":"2009","journal-title":"Biostatistics"},{"key":"10.1111\/ajt.13976_bib22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/ajt.12209","article-title":"Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C","volume":"13","author":"Fontana","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13976_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/lt.24366","article-title":"Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real world experience from HCV-TARGET","volume":"22","author":"Brown","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13976_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/MCG.0b013e31828a37c0","article-title":"A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors","volume":"47","author":"Chen","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/ajt.13976_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.13668","article-title":"Liver","volume":"16","author":"Kim","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13976_bib26","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s00268-012-1748-0","article-title":"The faltering solid organ donor pool in the United States (2001\u20132010)","volume":"36","author":"Saidi","year":"2012","journal-title":"World J Surg"},{"key":"10.1111\/ajt.13976_bib27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","article-title":"Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: A US National Transplant Registry analysis","volume":"23","author":"Northup","year":"2010","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.13976_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006\u20132012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.13976_bib29","first-page":"849","article-title":"Increases in heroin overdose deaths\u201428 states, 2010 to 2012","volume":"63","author":"Rudd","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/ajt.13976_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.12659\/AOT.892530","article-title":"Donor hepatitis C sero-status does not impact survival in liver transplantation","volume":"20","author":"Montenovo","year":"2015","journal-title":"Ann Transplant"},{"key":"10.1111\/ajt.13976_bib31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1432-2277.2012.01498.x","article-title":"Utilization of hepatitis C antibody-positive livers: Genotype dominance is virally determined","volume":"25","author":"O\u2019Leary","year":"2012","journal-title":"Transpl Int"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13976","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13976","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522248667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522248667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.13976\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:14:50Z","timestamp":1761628490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522248667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1600613522248667"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13976","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726611093.793568727","asserted-by":"object"}]},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in Utilization and Discard of Hepatitis C\u2013Infected Donor Livers in the Recent Era","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}